Internet-Based Interventions for MDD
- Conditions
- DepressionMedication Adherence
- Interventions
- Drug: antidepressant treatmentOther: antidepressant treatment combined with Internet-based interventions
- Registration Number
- NCT04684277
- Lead Sponsor
- Peking University
- Brief Summary
The acute and remission depression patients of 18-65 years old were recruited. At the time of enrollment, the demographic, symptomatic, neuropsychological and medication adherence data was collected. After the completion of the baseline assessment and examination, the patients were given antidepressant treatment or antidepressant treatment combined with Internet-based interventions. Clinical evaluation was performed at 1, 3 months (acute patients) and 6, 12 months (remission patients) after treatment, including the medication adherence, therapeutic efficacy, recurrence rate and functional rehabilitation. Through above work, this research is expected to provide clinicians with a set of Internet generalized technologies to improve the compliance and clinical outcomes of patients with depression, and to provide patients with treatment and management of the entire disease cycle.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 440
- age 18-65 years old, acute (HAMD17 > 17) and remission (HAMD17 < 8) depression
- other mental illnesses, serious somatic illnesses
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description antidepressant treatment antidepressant treatment recieve antidepressant treatment antidepressant treatment combined with Internet-based interventions antidepressant treatment combined with Internet-based interventions recieve antidepressant treatment combined with Internet-based interventions
- Primary Outcome Measures
Name Time Method recurrence rate 12 months The difference of recurrence rate between the two groups was compared
HAMD17 reduction ratio 3 months The difference of HAMD17 reduction ratio between the two groups was compared
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Yunai Su
🇨🇳Beijing, China